Company news
Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A (SZSE:300832) news
Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A news releases on 6ix. Latest, Jul 6, 2026: Shenzhen New Industries Biomedical Engineering's…
View Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A →
Press releases & updates
Shenzhen New Industries Biomedical Engineering's Actual Controller Under Detention
July 6, 2026
Shenzhen New Industries Biomedical Engineering : 2025 revenue rose 0.91% to ¥4.58B, with net profit down 11.39% amid strong overseas growth
April 27, 2026
Shenzhen New Industries Biomedical Engineering Q1 Net Profit Up 1% Y/Y
April 27, 2026
Shenzhen New Industries Biomedical Engineering Co: Revenue up 3.28% in Q3 2025, but net profit down 9.72% as domestic sales declined
October 28, 2025
New Industries Biomedical Q3 Net Profit Down 9.7% Y/Y
October 28, 2025
Shenzhen New Industries Biomedical Engineering Co: H1 2025 revenue fell 1.18% to ¥2.18B, net profit down 14.62%, overseas sales up 19.57%
August 25, 2025
Shenzhen New Industries Biomedical Engineering Co: 2024 revenue up 15.41%, net profit up 10.57%, strong global growth and high dividend
April 26, 2025
Shenzhen New Industries Biomedical Engineering Co: Double-digit revenue and profit growth, led by robust overseas expansion and innovation
April 8, 2025
Shenzhen New Industries Biomedical Engineering Co: Q3 revenue and profit rose double digits year-over-year, driven by strong product and market growth
October 29, 2024
Shenzhen New Industries Biomedical Engineering Co: Net profit surged 20.42% year-over-year on robust sales and margin gains
August 23, 2024